636. A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Live, Attenuated, Quadrivalent Dengue Vaccine (V181)

BACKGROUND: Dengue (DENV) is a mosquito-borne virus with four serotypes causing substantial morbidity in tropical and subtropical areas worldwide. A dengue vaccine that can be given to both seronegative and seropositive populations remains an important unmet medical need. V181 is an investigational...

Descripción completa

Detalles Bibliográficos
Autores principales: Russell, Kevin, Rupp, Richard E, Morales-Ramirez, Javier O, Diaz-Perez, Clemente, Andrews, Charles P, Lee, Andrew W, Finn, Tyler S, Cox, Kara, Russell, Amy Falk, Schaller, Margaret M, Martin, Jason C, Hyatt, Donna M, Gozlan-Kelner, Sabrina, Bili, Androniki, Coller, Beth-Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643940/
http://dx.doi.org/10.1093/ofid/ofab466.833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643940/
http://dx.doi.org/10.1093/ofid/ofab466.833

Ejemplares similares